Bill Text: TX HB2087 | 2019-2020 | 86th Legislature | Introduced


Bill Title: Relating to Schedule II controlled substance prescriptions under the Texas Controlled Substances Act.

Spectrum: Partisan Bill (Republican 1-0)

Status: (Introduced) 2019-03-06 - Referred to Public Health [HB2087 Detail]

Download: Texas-2019-HB2087-Introduced.html
  86R9520 JSC-D
 
  By: Dean H.B. No. 2087
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to Schedule II controlled substance prescriptions under
  the Texas Controlled Substances Act.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Section 481.003(a), Health and Safety Code, is
  amended to read as follows:
         (a)  The director may adopt rules to administer and enforce
  this chapter, other than Sections 481.073, 481.074, 481.075,
  481.0755, 481.076, 481.0761, 481.0762, 481.0763, 481.0764,
  481.0765, and 481.0766.  The board may adopt rules to administer
  Sections 481.073, 481.074, 481.075, 481.0755, 481.076, 481.0761,
  481.0762, 481.0763, 481.0764, 481.0765, and 481.0766.
         SECTION 2.  Subchapter C, Chapter 481, Health and Safety
  Code, is amended by adding Section 481.0755 to read as follows:
         Sec. 481.0755.  WRITTEN, ORAL, AND TELEPHONICALLY
  COMMUNICATED PRESCRIPTIONS FOR SCHEDULE II CONTROLLED SUBSTANCES.
  (a) Notwithstanding any other provision of this subchapter, a
  person prescribing or dispensing a Schedule II controlled substance
  must use the electronic prescription record and may not use a
  written, oral, or telephonically communicated prescription.
         (b)  A prescriber may issue a written, oral, or
  telephonically communicated prescription for a Schedule II
  controlled substance as authorized under this subchapter only if
  the prescription is issued in an emergency, as defined by board
  rule.
         (c)  A written, oral, or telephonically communicated
  prescription must comply with the applicable requirements
  prescribed by Sections 481.074 and 481.075.
         SECTION 3.  Section 481.128(a), Health and Safety Code, is
  amended to read as follows:
         (a)  A registrant or dispenser commits an offense if the
  registrant or dispenser knowingly:
               (1)  distributes, delivers, administers, or dispenses
  a controlled substance in violation of Sections 481.070-481.0755
  [481.070-481.075];
               (2)  manufactures a controlled substance not
  authorized by the person's Federal Drug Enforcement Administration
  registration or distributes or dispenses a controlled substance not
  authorized by the person's registration to another registrant or
  other person;
               (3)  refuses or fails to make, keep, or furnish a
  record, report, notification, order form, statement, invoice, or
  information required by this chapter;
               (4)  prints, manufactures, possesses, or produces an
  official prescription form without the approval of the board;
               (5)  delivers or possesses a counterfeit official
  prescription form;
               (6)  refuses an entry into a premise for an inspection
  authorized by this chapter;
               (7)  refuses or fails to return an official
  prescription form as required by Section 481.075(k);
               (8)  refuses or fails to make, keep, or furnish a
  record, report, notification, order form, statement, invoice, or
  information required by a rule adopted by the director or the board;
  or
               (9)  refuses or fails to maintain security required by
  this chapter or a rule adopted under this chapter.
         SECTION 4.  Section 481.129(a), Health and Safety Code, is
  amended to read as follows:
         (a)  A person commits an offense if the person knowingly:
               (1)  distributes as a registrant or dispenser a
  controlled substance listed in Schedule I or II, unless the person
  distributes the controlled substance as authorized under the
  federal Controlled Substances Act (21 U.S.C. Section 801 et seq.);
               (2)  uses in the course of manufacturing, prescribing,
  or distributing a controlled substance a Federal Drug Enforcement
  Administration registration number that is fictitious, revoked,
  suspended, or issued to another person;
               (3)  issues a prescription bearing a forged or
  fictitious signature;
               (4)  uses a prescription issued to another person to
  prescribe a Schedule II controlled substance;
               (5)  possesses, obtains, or attempts to possess or
  obtain a controlled substance or an increased quantity of a
  controlled substance:
                     (A)  by misrepresentation, fraud, forgery,
  deception, or subterfuge;
                     (B)  through use of a fraudulent prescription
  form; [or]
                     (C)  through use of a fraudulent oral or
  telephonically communicated prescription; or
                     (D)  through the use of a fraudulent electronic
  prescription; or
               (6)  furnishes false or fraudulent material
  information in or omits material information from an application,
  report, record, or other document required to be kept or filed under
  this chapter.
         SECTION 5.  Section 554.051(a-1), Occupations Code, is
  amended to read as follows:
         (a-1)  The board may adopt rules to administer Sections
  481.073, 481.074, 481.075, 481.0755, 481.076, 481.0761, 481.0762,
  481.0763, 481.0764, 481.0765, and 481.0766, Health and Safety Code.
         SECTION 6.  Section 565.003, Occupations Code, is amended to
  read as follows:
         Sec. 565.003.  ADDITIONAL GROUNDS FOR DISCIPLINE REGARDING
  APPLICANT FOR OR HOLDER OF NONRESIDENT PHARMACY LICENSE. Unless
  compliance would violate the pharmacy or drug statutes or rules in
  the state in which the pharmacy is located, the board may discipline
  an applicant for or the holder of a nonresident pharmacy license if
  the board finds that the applicant or license holder has failed to
  comply with:
               (1)  Section 481.073, 481.074, [or] 481.075, 481.0755,
  481.076, 481.0761, 481.0762, 481.0763, 481.0764, 481.0765, or
  481.0766, Health and Safety Code;
               (2)  Texas substitution requirements regarding:
                     (A)  the practitioner's directions concerning
  generic substitution;
                     (B)  the patient's right to refuse generic
  substitution; or
                     (C)  notification to the patient of the patient's
  right to refuse substitution;
               (3)  any board rule relating to providing drug
  information to the patient or the patient's agent in written form or
  by telephone; or
               (4)  any board rule adopted under Section 554.051(a)
  and determined by the board to be applicable under Section
  554.051(b).
         SECTION 7.  The change in law made by this Act applies only
  to a prescription issued on or after the effective date of this Act.
  A prescription issued before the effective date of this Act is
  governed by the law in effect immediately before the effective date
  of this Act, and the former law is continued in effect for that
  purpose.
         SECTION 8.  This Act takes effect September 1, 2019.
feedback